Cima et al. - 2018 - A multidisciplinary european guideline for tinnitus
Guidelines for Tinnitus Management
Contributors and Institutions
- Authors: R. F. F. Cima (Maastricht University, Netherlands), B. Mazurek (Charité—Universitätsmedizin Berlin, Germany), H. Haider (Hospital Cuf Infante Santo, Portugal), D. Kikidis (University of Athens, Greece), A. Lapira (Malta University, Malta), A. Noreña (Aix-Marseille Université, France), D. J. Hoare (University of Nottingham, UK).
- Contributors: A. Agius, A. Londero, A. Clarke, etc.
Content Overview
General Introduction - Motivation for the guideline. - Aim of the guideline. - Delineation and intended users of the guideline. - Main classifications for subjective tinnitus. - Epidemiology and pathophysiology of tinnitus. - Mechanisms of tinnitus awareness and distress. - Theoretical models of tinnitus.
Methods - Introduction to the guideline development process. - Preparatory work leading to the guideline formation. - Consultation rounds and consensus building.
Diagnostics, Assessments, and Outcomes - Introduction to diagnostic criteria. - Minimum patient assessments and further assessment options. - Use of assessment questionnaires.
Treatment Options and Referral Pathways - Available treatments and evidence base for each. - Referral options and treatment criteria.
Patient Information and Support - Importance of confirming knowledge and dispelling myths. - Types of information that should be provided to patients. - Resources for further support.
Chapter 1: General Introduction
1.1 Motivation for the guideline - Tinnitus is the perception of sound without external stimulus; can be distressing for some individuals. - Objective vs. subjective tinnitus. - Need for standardized assessment and treatment due to the complex nature of tinnitus and diverse patient profiles.
1.2 Aim of the guideline - Establish uniformity in assessment and treatment of adult patients with subjective tinnitus. - Optimize referral trajectories, minimize over- and under-treatment. - Support shared decision-making in clinical practice.
1.3 Intended users - Health professionals (ENT doctors, audiologists, psychologists, etc.) and stakeholders including researchers and patients.
1.5 Main classifications for subjective tinnitus - Acute (
Chapter 3: Diagnostics, Assessments, and Outcomes
3.1 Introduction - Numerous factors contribute to tinnitus onset; a comprehensive assessment is critical.
3.2 Minimum patient assessment - Fundamental patient history should include onset, modulation, severity, and impact assessments (using validated questionnaires).
3.4 Assessment by questionnaires - Recommended assessments include Tinnitus Handicap Inventory (THI), Tinnitus Questionnaire (TQ), and more to evaluate severity/distress.
Chapter 4: Treatment Options and Referral Pathways
- 4.1 Available treatments - Cognitive Behavioral Therapy (CBT) is highly recommended. - Medication options are limited; strong recommendation against drug treatments specifically for tinnitus.
- 4.2 Referral options - Referral for psychological or audiological assessment based on screening results.
Chapter 5: Patient Information and Support
5.1 Confirming knowledge and dispelling myths - Educating patients about tinnitus, treatment strategies, and dispelling common misconceptions (e.g., tinnitus leading to deafness).
5.2 Information provided to patients - Key information includes treatment options, coping strategies, and understanding of tinnitus.
5.3 Further information - Support from national charities, professional organizations, and helplines.
Appendices
- Appendix A: Management of Pulsatile Tinnitus
- Appendix B: Development of the guideline implementation plan
- Appendix C & D: Further details on somatosensory tinnitus and related quality-of-life instruments.
Clinical Considerations for Tinnitus Management
- Importance of interdisciplinary approaches involving audiologists, psychologists, and ENT specialists.
- Emphasis on educating patients about the expected outcomes and available coping mechanisms, ensuring ongoing communication and support throughout their treatment journey.